Hearing Loss and Dementia: The Biggest Modifiable Risk | Philadelphia

TL;DR30-second take

Hearing loss is the largest single modifiable risk factor for dementia, identified by the Lancet Commission as accounting for roughly 8% of cases. The link runs through cognitive strain, social isolation, and brain changes. Treating hearing loss may help: in a 2023 trial, hearing aids slowed cognitive decline by about half in older adults at higher risk, though not in the healthier group overall. Hearing loss is badly undertreated. Fishtown Medicine screens for it and builds hearing into a brain-health prevention plan.

TL;DR: Of all the things that raise dementia risk and can be changed, hearing loss is the single biggest one, according to the Lancet Commission on dementia. It is also one of the most ignored, often going untreated for 7 to 10 years after it begins. The link is not a coincidence: struggling to hear strains the brain, drives social withdrawal, and is tied to faster brain shrinkage. The encouraging part is that treatment may help. In a 2023 trial, hearing aids slowed cognitive decline by roughly half in older adults at higher risk, even though the healthier group overall did not show a clear benefit. At Fishtown Medicine we treat hearing as part of brain-health prevention rather than an afterthought handled decades too late.

If you or a parent has been turning up the television, missing words in restaurants, or nodding along without quite catching the conversation, this page matters. Hearing loss is easy to dismiss as a normal, harmless part of aging, and while it is common, harmless is the wrong word. It is one of the most important and most treatable levers in protecting the aging brain. Here is why the connection is strong and what to do about it.

Is hearing loss really a dementia risk factor?

Yes, and it is the largest modifiable one identified so far. The Lancet Commission on dementia prevention, which reviews the evidence on what raises dementia risk and can be changed, has ranked hearing loss in midlife as the single biggest modifiable contributor, estimated to account for about 8% of all dementia cases.¹ A 2024 update to that work kept hearing loss among the leading factors on a list that, taken together, is tied to close to half of dementia risk.⁴

The foundational research showed that people with hearing loss develop dementia at higher rates than those without, with the risk rising as the hearing loss worsens.³ Moderate hearing loss carries several times the risk of no hearing loss in some studies. This is an association drawn from observational data, so it cannot prove cause on its own, but the size of the effect, the dose-response pattern, and the mechanisms behind it make it one of the more compelling risk relationships in brain health.

Why does hearing loss raise dementia risk?

Hearing loss appears to raise dementia risk through several overlapping pathways, which is part of why the link is taken seriously. There are three main explanations, and they likely work together:

Cognitive load. When hearing is degraded, the brain has to work harder to decode speech, pulling resources away from memory and thinking to keep up. Over years, that constant strain may wear on cognitive reserve.
Social isolation. Struggling to follow conversations leads many people to withdraw from social life, and social isolation is itself a well-established dementia risk factor. Less conversation means less of the mental stimulation that helps protect the brain.
Brain change. Reduced input to the hearing centers of the brain is associated with faster atrophy in related regions, and hearing loss shares vascular and other risk factors with dementia.

Together these mean hearing loss is more than a marker sitting alongside dementia; there are plausible ways it actively contributes, which is what makes treating it promising rather than futile.

Do hearing aids reduce the risk of dementia?

This is where the evidence is encouraging and also more nuanced than the headlines. The largest test to date, the ACHIEVE trial, randomly assigned older adults with hearing loss to either a hearing intervention (hearing aids plus support) or a health-education program, then followed their thinking over three years. In the overall group of relatively healthy older adults, the hearing intervention did not clearly slow cognitive decline.²

The important finding was in the subgroup at higher risk, older adults who already had more risk factors for cognitive decline. In that group, the hearing intervention slowed the loss of thinking ability by about 48% over the three years.² The fair reading is that treating hearing loss is most likely to protect cognition in those whose risk is already elevated, and that the intervention is safe, improves communication and quality of life for everyone, and carries meaningful upside for the brain in the people most likely to benefit. Given how low the downside is, treating meaningful hearing loss is a sound move.

What can you do about hearing loss and brain health?

The practical steps are within reach, and several have become easier in the last few years:

Get your hearing tested, particularly if you or those around you notice you missing words, asking for repeats, or struggling in noisy rooms. Hearing loss comes on slowly and is easy to underestimate.
Treat meaningful hearing loss rather than waiting. The old pattern of enduring it for a decade before acting is the opposite of what brain health calls for.
Use hearing aids, which are now more accessible. A 2022 change made some hearing aids available over the counter, lowering the cost and hassle that kept many people from treatment.
Protect the hearing you have from loud noise, a major and preventable cause of hearing loss over a lifetime.
Address the other modifiable risks too, since hearing is one of many levers; blood pressure, metabolic health, physical activity, and social connection all matter for the same brain.

Longevity Medicine

A personalized longevity strategy starts with knowing your real baselines.

Start Your Longevity Assessment

How Fishtown Medicine approaches hearing and brain health in Philadelphia

We treat hearing as part of the brain-health conversation rather than a separate issue to be handled by someone else years too late. That means asking about it, taking reported changes seriously, and folding hearing into the wider prevention plan alongside the cardiovascular, metabolic, and lifestyle factors that shape cognitive risk. When someone notices a change, we make sure it gets evaluated rather than waved off as ordinary aging.

The formal hearing testing and hearing-aid fitting are done by audiology, so when that step is needed we refer to highly qualified specialists who are in network for you and coordinate the results into your plan. For complex cognitive concerns we compare notes across a network of specialists, so you get the right input without a scattered set of disconnected visits. Whether you are in Fishtown or Rittenhouse, or across the bridge in Cherry Hill or Moorestown, the aim is to catch and treat hearing loss early, as one of the most actionable things you can do for a longer, sharper life.

Guidance from the Clinic

"When patients ask me what they can do to protect their brain, they expect me to talk about crosswords or a supplement. One of the first things I bring up is hearing. It is the biggest modifiable dementia risk factor we know of, and it is one people put off treating for years because a hearing aid feels like admitting you are old. I would rather someone treat a meaningful hearing loss at 60 than white-knuckle through it until 70. It helps them stay connected, and the evidence says it may help protect their thinking, particularly if their risk is already up."

Key Takeaways

Hearing loss is the single largest modifiable dementia risk factor, tied to roughly 8% of cases by the Lancet Commission.
The link runs through cognitive strain, social isolation, and brain changes - plausible ways it actively contributes rather than a passive marker.
Treating it may protect cognition: the 2023 ACHIEVE trial slowed decline by about 48% in higher-risk older adults, though not in the healthier group overall.
Hearing loss is badly undertreated, often ignored for 7 to 10 years; over-the-counter hearing aids have made treatment more accessible.
It is one lever among several - blood pressure, metabolic health, activity, and social connection protect the same brain.
Fishtown Medicine builds hearing into brain-health prevention in Philadelphia and South Jersey, coordinating with in-network audiology.

The Four Horsemen: The Diseases That End Most Lives - where dementia fits the longevity picture
Family History and a Prevention Plan - building prevention around your inherited risk
Muscle Is the Organ of Longevity - another proven lever for aging well
Metabolic Health and Insulin Resistance - the metabolic risks shared with brain health
Longevity Medicine in Philadelphia - how the prevention levers come together

Scientific References

Livingston G, Huntley J, Sommerlad A, et al. "Dementia prevention, intervention, and care: 2020 report of the Lancet Commission." Lancet. 2020;396(10248):413-446.
Lin FR, Pike JR, Albert MS, et al. "Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial." Lancet. 2023;402(10404):786-797.
Lin FR, Metter EJ, O'Brien RJ, Resnick SM, Zonderman AB, Ferrucci L. "Hearing Loss and Incident Dementia." Archives of Neurology. 2011;68(2):214-220.
Livingston G, Huntley J, Liu KY, et al. "Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission." Lancet. 2024;404(10452):572-628.

Fishtown Medicine | Longevity

2418 E York St, Philadelphia, PA 19125(267) 360-7927 hello@fishtownmedicine.comHSA/FSA Eligible

Start your intake

Frequently Asked Questions

Common Questions

Hearing loss is strongly associated with a higher risk of dementia, and the Lancet Commission ranks it as the largest single modifiable risk factor, tied to about 8% of cases. Whether it directly causes dementia cannot be proven from observational data alone, but the mechanisms, cognitive strain, social isolation, and brain changes, give plausible ways it contributes. Treating hearing loss is a reasonable step to protect the brain, particularly given how low the risk of treatment is.

Hearing aids have not been proven to prevent dementia in everyone, but the evidence is encouraging in higher-risk people. In the 2023 ACHIEVE trial, a hearing intervention slowed cognitive decline by about 48% over three years in older adults who already had more risk factors, though it did not show a clear benefit in the healthier group overall. Since hearing aids also improve communication and quality of life with little downside, treating meaningful hearing loss is a sound choice.

You should treat meaningful hearing loss when it starts affecting communication, rather than waiting the 7 to 10 years many people delay. Early treatment keeps you connected socially, reduces the cognitive strain of struggling to hear, and may better protect the brain than treating it late. Getting a hearing test at the first sign of trouble, missing words or needing the volume up, is the right first step.

Over-the-counter hearing aids, made available by a 2022 rule change, are a reasonable option for many people with mild to moderate hearing loss and have lowered the cost and hassle that kept people from treatment. For more significant hearing loss or complex needs, a professional audiology evaluation and fitting are worth it. The most important thing is treating the hearing loss at all; the access improvement makes that easier than it used to be.

Deep-Dive Questions

Hearing loss is the largest modifiable dementia risk factor because it is both common and impactful, and because it acts through several reinforcing pathways at once. Its population impact is large simply because so many people develop hearing loss in midlife and later, so even a moderate per-person effect adds up across a population. On the individual level, degraded hearing forces the brain into constant extra effort to understand speech, promotes the social withdrawal that removes protective mental stimulation, and is linked to accelerated shrinkage in brain regions tied to hearing and memory. Because these mechanisms are plausible and potentially reversible with treatment, hearing loss stands out on the modifiable list: it is widespread, it is measurable, and unlike some risk factors, there is a concrete intervention in hearing aids.

The ACHIEVE trial helped higher-risk people but not the overall group most likely because the healthier participants were declining so slowly that there was little decline for the intervention to slow over three years. The study drew from two populations: a group of generally healthy volunteers and a group from a long-running heart-health study who carried more risk factors and were declining faster. In the faster-declining, higher-risk group, treating hearing loss slowed cognitive decline by roughly half, while the healthier group changed little in either arm, leaving no gap to detect in the timeframe. This pattern is common in prevention research, where an intervention shows its value most clearly in those with the most to lose. It suggests that treating hearing loss is particularly worthwhile for older adults who already carry cognitive risk, without arguing against treating it in anyone whose hearing loss affects their life.

Hearing fits into brain-health prevention as one of a set of modifiable levers that together account for a large share of dementia risk, which is why it is best addressed alongside the others rather than in isolation. The same Lancet work that highlights hearing also names factors like high blood pressure, physical inactivity, diabetes, social isolation, and, in its later update, high cholesterol and vision loss. Many of these overlap with cardiovascular and metabolic health, meaning the ApoB, blood pressure, and insulin resistance we already work to control double as brain protection. Treating hearing loss adds a distinct and powerful lever to that list, and combining it with the cardiovascular, metabolic, and social pieces is how a prevention plan meaningfully lowers the odds of decline, since no single factor tells the whole story.

Ready when you are